Success Stories

Success Story Clinical Trial Newly developed radiopharmaceuticals detect and destroy micro- metastases Prostate cancer is the most common cancer in men and the second leading cause of cancer-related death in men. Improving treatment outcomes for patients with advanced prostate cancer is the goal of PROGNOSTICS, a phase-1 clinical trial funded…